MiR-129-5p Targets Wnt5a to Block PKC/ERK/NF-κB and JNK Pathways in Glioblastoma

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2018 Mar 14

PMID 29531296

Citations 49

Authors

Ailiang Zeng

Jianxing Yin

Yan Li

Rui Li

Zheng Wang

Xu Zhou

Xin Jin

Feng Shen

Wei Yan

Yongping You

Affiliations

Soon will be listed here.

Abstract

Therapeutic application of microRNAs (miRNAs) in Wnt-driven glioma has been valuable; however, their specific roles and mechanisms have not been completely investigated. Real-time quantitative PCR (RT-qPCR) was used to analyse the expression of microRNA-129-5p (miR-129-5p) in human glioma samples. Cell-Counting Kit 8 (CCK-8), flow cytometry, EdU, angiogenesis, Transwell invasion, wound healing, in vitro 3D migration and neurosphere formation assays were employed to assess the role of miR-129-5p in glioblastoma multiforme (GBM) cells. Moreover, we performed the luciferase reporter assay and the RNA-ChIP (chromatin immunoprecipitation) assay to confirm whether Wnt5a was a direct target of miR-129-5p. We also confirmed the correlation between the expression profile of miR-129-5p and Wnt5a in glioma patients from the Chinese Glioma Genome Atlas (CGGA) and investigated the overall survival of GBM patients using two data sets, namely, TCGA and GSE16011, according to their Wnt5a expression status. MiR-129-5p expression levels were downregulated and inversely correlated with Wnt5a expression levels in CGGA glioma patients. Restored expression of miR-129-5p blocked GBM cell proliferation, invasion, migration, angiogenesis, neurosphere formation and resistance to temozolomide. We reported that miR-129-5p directly targeted Wnt5a in glioma. Furthermore, we observed that overexpression of miR-129-5p inhibited the expression of Wnt5a, thus blocking the protein kinase C(PKC)/ERK/NF-κB and JNK pathways. Inhibiting Wnt5a rescued the effects of miR-129-5p loss and increased Wnt5a expression was associated with reduced overall survival of GBM patients. We also demonstrated the inhibitory effect of miR-129-5p on tumour growth in GBM using an in vivo model. The miR-129-5p/Wnt5a-axis-mediated PKC/ERK/NF-κB and JNK pathways have therapeutic potential in GBM treatment.

Citing Articles

Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide.

Goleij P, Pourali G, Raisi A, Ravaei F, Golestan S, Abed A Mol Neurobiol. 2024; 62(2):1726-1755.

PMID: 39023794 DOI: 10.1007/s12035-024-04316-z.

MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.

Palizkaran Yazdi M, Barjasteh A, Moghbeli M Mol Brain. 2024; 17(1):42.

PMID: 38956588 PMC: 11218189. DOI: 10.1186/s13041-024-01113-6.

Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.

Kashani E, Schnidrig D, Gheinani A, Ninck M, Zens P, Maragkou T Neuro Oncol. 2022; 25(4):662-673.

PMID: 36124685 PMC: 10076939. DOI: 10.1093/neuonc/noac220.

Extracellular Vesicles Derived From Hypoxia-Conditioned Adipose-Derived Mesenchymal Stem Cells Enhance Lymphangiogenesis.

Yang Y, Li X, Li Y, Li T, Li P, Deng G Cell Transplant. 2022; 31:9636897221107536.

PMID: 35861534 PMC: 9310282. DOI: 10.1177/09636897221107536.

Up-regulation of LINC00665 contributes to the progression of glioma and correlates with its MRI characteristics.

Chen W, Hong L, Hou C, Zong G, Zhang J Am J Transl Res. 2022; 14(5):2988-3002.

PMID: 35702084 PMC: 9185054.

References

Lucon D, de Souza Rocha C, Craveiro R, Dilloo D, Cardinalli I, Cavalcanti D . Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma. Front Oncol. 2013; 3:254. PMC: 3782711. DOI: 10.3389/fonc.2013.00254. View

Jiang Z, Wang H, Li Y, Hou Z, Ma N, Chen W . MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8. Neoplasma. 2016; 63(5):673-80. DOI: 10.4149/neo_2016_503. View

Wakimoto H, Kesari S, Farrell C, Curry Jr W, Zaupa C, Aghi M . Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 2009; 69(8):3472-81. PMC: 2785462. DOI: 10.1158/0008-5472.CAN-08-3886. View

OConnell M, Fiori J, Xu M, Carter A, Frank B, Camilli T . The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2009; 29(1):34-44. PMC: 2803338. DOI: 10.1038/onc.2009.305. View

Shi Z, Chen Q, Li C, Wang L, Qian X, Jiang C . MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro Oncol. 2014; 16(10):1341-53. PMC: 4165420. DOI: 10.1093/neuonc/nou084. View

Asem M, Buechler S, Wates R, Miller D, Stack M . Wnt5a Signaling in Cancer. Cancers (Basel). 2016; 8(9). PMC: 5040981. DOI: 10.3390/cancers8090079. View

Beier D, Schulz J, Beier C . Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. Mol Cancer. 2011; 10:128. PMC: 3207925. DOI: 10.1186/1476-4598-10-128. View

Luo H, Chen Z, Wang S, Zhang R, Qiu W, Zhao L . c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. Brain. 2015; 138(Pt 12):3654-72. DOI: 10.1093/brain/awv287. View

Kim Y, Hong M, Do I, Ha S, Lee D, Suh Y . Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. Pathol Res Pract. 2015; 211(12):963-72. DOI: 10.1016/j.prp.2015.10.001. View

10.

Zhang S, Huang W, Li P, Guo H, Poh S, Brady S . Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med. 2011; 17(4):461-9. PMC: 3877934. DOI: 10.1038/nm.2309. View

11.

Hui W, Yuntao L, Lun L, WenSheng L, Chaofeng L, Haiyong H . MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One. 2013; 8(1):e54932. PMC: 3557299. DOI: 10.1371/journal.pone.0054932. View

12.

Tan G, Cao X, Dai Q, Zhang B, Huang J, Xiong S . A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Oncotarget. 2015; 6(11):8676-86. PMC: 4496175. DOI: 10.18632/oncotarget.3254. View

13.

Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999; 18(49):6938-47. DOI: 10.1038/sj.onc.1203221. View

14.

Duan L, Hao X, Liu Z, Zhang Y, Zhang G . MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET. FEBS Lett. 2014; 588(9):1644-51. DOI: 10.1016/j.febslet.2014.03.002. View

15.

Song H, Zhang Y, Liu N, Zhao S, Kong Y, Yuan L . miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways. Int J Mol Sci. 2016; 17(11). PMC: 5133800. DOI: 10.3390/ijms17111799. View

16.

Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas D . Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004; 23(58):9392-400. DOI: 10.1038/sj.onc.1208311. View

17.

Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro J . Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci U S A. 2008; 105(8):3047-52. PMC: 2268582. DOI: 10.1073/pnas.0712148105. View

18.

Xu H, Hu Y, Qiu W . Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B. Biomed Pharmacother. 2017; 87:405-411. DOI: 10.1016/j.biopha.2016.12.100. View

19.

Dossing K, Binderup T, Kaczkowski B, Jacobsen A, Rossing M, Winther O . Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1. Genes (Basel). 2014; 6(1):1-21. PMC: 4377830. DOI: 10.3390/genes6010001. View

20.

Yu Y, Zhao Y, Sun X, Ge J, Zhang B, Wang X . Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer. Oncotarget. 2015; 6(33):34423-36. PMC: 4741463. DOI: 10.18632/oncotarget.5406. View